BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹7.39 Cr | ₹2.57 Cr | ₹5.61 Cr | ₹4.74 Cr | ₹-12 Cr |
What is the latest Consolidated Net Profit of BAL PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹7.39 Cr |
Mar2023 | ₹2.57 Cr |
Mar2022 | ₹5.61 Cr |
Mar2021 | ₹4.74 Cr |
Mar2020 | ₹-12 Cr |
How is Consolidated Net Profit of BAL PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹7.39 Cr | 187.40 | |
Mar2023 | ₹2.57 Cr | -54.17 | |
Mar2022 | ₹5.61 Cr | 18.35 | |
Mar2021 | ₹4.74 Cr | Positive | |
Mar2020 | ₹-12 Cr | - |
Compare Consolidated Net Profit of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹175.9 Cr | -2.8% | -7.8% | -8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -2.8% |
-7.8% |
-8.9% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses